文献速递泌尿生殖与妇科肿瘤放疗放疗物理与技术

支持前列腺癌肿瘤靶向高剂量率近距离放疗的多模态影像引导与剂量规划集成系统的性能

Performance of an integrated multimodality image guidance and dose-planning system supporting tumor-targeted HDR brachytherapy for prostate cancer.
PubMed 文献 · Radiother Oncol · 2021-11-30

该前瞻性研究在43例连续操作中评估了一套集成多模态影像配准与电磁跟踪的原型系统,用于前列腺癌高剂量率近距离放疗。结果显示局灶植入平均操作时间38分钟、全腺植入56分钟,电磁导管重建平均误差0.8毫米,配准精度在尿道对齐旋转与弹性配准后改善(mTRE 3.42毫米)。系统支持肿瘤靶向且无明显学习曲线,但影像配准误差仍存在。

要点

  • 局灶近距离放疗平均操作时间38分钟,全腺植入56分钟,随时间保持稳定。
  • 电磁导管重建计算与实测自由长度平均差0.8毫米,轴向手动校正平均1.3毫米。
  • 尿道对齐的y轴旋转与弹性配准改善了配准精度,mTRE为3.42毫米(SD 1.49)。

核心结论

  • 该系统支持肿瘤靶向操作,实施过程中无明显学习曲线。
  • 电磁重建误差小、可校正,并通过校准和控制外部失真源得到改善,增加了对部分可见导管使用的信心。
  • 尽管进行了旋转对齐和形变处理,影像配准误差仍然存在,应仔细考虑。

研究设计与样本

  • 前瞻性研究,在临床部署后连续评估43例操作。
  • 队列包括32例局灶近距离放疗和11例集成boost全腺植入。
  • 测量工作流程效率与电磁导管重建精度,并评估MRI-TRUS配准精度(有无形变、有无y轴旋转用于初始化时尿道对齐)。

主要发现

  • 排除剂量投照的平均操作时间:局灶植入38分钟(范围21-83),全腺植入56分钟(范围38-89),随时间保持稳定。
  • 电磁导管重建计算与实测自由长度的平均差为0.8毫米(SD 0.8,未进行校正),轴向手动校正平均1.3毫米(SD 0.7)。
  • 电磁跟踪使21%的操作中能够临床使用不可见或部分可见的导管。
  • 配准精度在初始化时尿道对齐的y轴旋转和弹性配准后改善,mTRE为3.42毫米(SD 1.49)。

局限性

  • 尽管进行了旋转对齐和形变处理,影像配准误差仍然存在,应仔细考虑。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Advances in high-dose-rate brachytherapy to treat prostate cancer hinge on improved accuracy in navigation and targeting while optimizing a streamlined workflow. Multimodal image registration and electromagnetic (EM) tracking are two technologies integrated into a prototype system in the early phase of clinical evaluation. We aim to report on the system's accuracy and workflow performance in support of tumor-targeted procedures. MATERIALS AND METHODS: In a prospective study, we evaluated the system in 43 consecutive procedures after clinical deployment. We measured workflow efficiency and EM catheter reconstruction accuracy. We also evaluated the system's MRI-TRUS registration accuracy with/without deformation, and with/without y-axis rotation for urethral alignment at initialization. RESULTS: The cohort included 32 focal brachytherapy and 11 integrated boost whole-gland implants. Mean procedure time excluding dose delivery was 38 min (range: 21-83) for focal, and 56 min (range: 38-89) for whole-gland implants; stable over time. EM catheter reconstructions achieved a mean difference between computed and measured free-length of 0.8 mm (SD 0.8, no corrections performed), and mean axial manual corrections 1.3 mm (SD 0.7). EM also enabled the clinical use of a non or partially visible catheter in 21% of procedures. Registration accuracy improved with y-axis rotation for urethral alignment at initialization and with the elastic registration (mTRE 3.42 mm, SD 1.49). CONCLUSION: The system supported tumor-targeting and was implemented with no demonstrable learning curve. EM reconstruction errors were small, correctable, and improved with calibration and control of external distortion sources; increasing confidence in the use of partially visible catheters. Image registration errors remained despite rotational alignment and deformation, and should be carefully considered.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Grajales D, Kadoury S, Shams R, et al. Performance of an integrated multimodality image guidance and dose-planning system supporting tumor-targeted HDR brachytherapy for prostate cancer. Radiother Oncol. 2021. PMID: 34861267. doi:10.1016/j.radonc.2021.11.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。